Neutropenia severa inducida por propiltiuracilo / (Severe neutropenia induced by propylthiuracil)
Acta méd. costarric
; 60(1): 45-47, ene.-mar. 2018. tab
Article
in Es
| LILACS
| ID: biblio-886401
Responsible library:
CR1.1
RESUMEN
Resumen Los pacientes con hipertiroidismo tienen varias opciones de tratamiento. El tratamiento de la enfermedad de Graves consiste en bloquear el exceso de hormonas tiroideas empleando tionamidas, tiroidectomía o terapia con I131. Los agentes antitiroideos como el metimazol, carbimazole, propiltiuracilo, son efectivos para controlar el hipertirodismo en pacientes con enfermedad de Graves, pero tienen efectos adversos incluyendo, alergias, gastritis, hepatitis y agranulocitosis. Se presenta un paciente hipertiroideo con neutropenia severa durante tratamiento con propiltiuracilo.
ABSTRACT
Abstract Patients with hyperthyroidism have several treatment options. The treatment of Graves' disease consists of blocking the excess of thyroid hormones using thionamides, thyroidectomy or I131 therapy. Antithyroid agents such as methimazole, carbimazole, propylthiuracil are effective in controlling hyperthyroidism in patients with Graves' disease, but they have adverse effects including, allergies, gastritis, hepatitis and agranulocytosis. We present a hyperthyroid patient with severe neutropenia during treatment with propylthiuracil.
Key words
Full text:
1
Collection:
01-internacional
Database:
LILACS
Main subject:
Propylthiouracil
/
Graves Disease
/
Hyperthyroidism
Limits:
Adult
/
Female
/
Humans
Country/Region as subject:
America central
/
Costa rica
Language:
Es
Journal:
Acta méd. costarric
Journal subject:
MEDICINA
Year:
2018
Document type:
Article
Affiliation country:
Costa Rica
Country of publication:
Costa Rica